BioScience Health Innovations annual operating margin
2023
2024
2025
BioScience Health Innovations's operating margin was 12.64% for fiscal 2025.
View full BioScience Health Innovations company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 12.64% | +7.92 pp |
| 2024 | 2024-12-31 | 4.72% | +46.80 pp |
| 2023 | 2023-12-31 | −42.09% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −21.02% | −47.07 pp |
| Q1 2026 | 2026-03-31 | −30.62% | −65.40 pp |
| Q4 2025 | 2025-12-31 | −9.96% | −11.59 pp |
| Q3 2025 | 2025-09-30 | −0.78% | −10.59 pp |
| Q2 2025 | 2025-06-30 | 26.04% | +6.72 pp |
| Q1 2025 | 2025-03-31 | 34.78% | +54.01 pp |
| Q4 2024 | 2024-12-31 | 1.63% | +14.27 pp |
| Q3 2024 | 2024-09-30 | 9.81% | +39.55 pp |
| Q2 2024 | 2024-06-30 | 19.32% | +142.06 pp |
| Q1 2024 | 2024-03-31 | −19.23% | +199.46 pp |
| Q4 2023 | 2023-12-31 | −12.64% | +416.74 pp |
| Q3 2023 · Sep 30 | 2023-09-30 | −29.74% | −6.41 pp |
| Q3 2023 · Jun 30 | 2023-06-30 | −122.74% | +1386.58 pp |
| Q2 2023 · Mar 31 | 2023-03-31 | −218.68% | — |
| Q3 2023 · Sep 30 | 2022-09-30 | −429.38% | — |
| Q3 2022 · Jun 30 | 2022-06-30 | −23.33% | — |
| Q2 2022 · Mar 31 | 2022-03-31 | −1,509.32% | — |
Across the available reported history, BioScience Health Innovations's operating margin increased from 4.72% to 12.64%, a change of +7.92 percentage points. The latest reported quarter, Q2 2026, shows −21.02%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioScience Health Innovations filings at SEC.gov ↗